BDB562962

TGF-Beta 1 Mouse anti-Human, Brilliant Violet 421, Clone: TW4-9E7, BD

Manufacturer: BD Biosciences

Select a Size

Pack Size SKU Availability Price
Each of 1 BDB562962-Each-of-1 In Stock ₹ 27,234.00

BDB562962 - Each of 1

₹ 27,234.00

In Stock

Quantity

1

Base Price: ₹ 27,234.00

GST (18%): ₹ 4,902.12

Total Price: ₹ 32,136.12

Antigen

TGF-Beta 1

Classification

Monoclonal

Conjugate

Brilliant Violet 421

Formulation

Aqueous buffered solution containing BSA and ≤0.09% sodium azide.

Immunogen

Human TGF-β1 Transfected Cell Line

Quantity

50 Tests

Primary or Secondary

Primary

Content And Storage

Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.

Applications

Flow Cytometry

Clone

TW4-9E7

Description

TGFB1; TGFbeta1; TGF-beta-1; Transforming growth factor, beta 1; CED; LAP

Host Species

Mouse

Purification Method

Affinity Purified

Regulatory Status

RUO

Target Species

Human

Isotype

IgG1 κ

Related Products

Img

BD Biosciences

BDB562544

--

Img

BD Biosciences

BDB562517

--

Img

BD Biosciences

BDB562260

--

Img

BD Biosciences

BDB563161

--

Img

BD Biosciences

BDB563131

--

Img

BD Biosciences

BDB563072

--

Img

BD Biosciences

BDB562613

--

Img

BD Biosciences

BDB563740

--

Description

  • The TW4-9E7 monoclonal antibody specifically binds to Human Transforming Growth Factor beta-1 (TGF-β1)
  • TGF-β1 is a potent multifunctional cytokine that positively or negatively regulates numerous processes including development, hematopoiesis, tissue remodeling, wound repair, innate and adaptive immunity as well as cancer and autoimmune diseases
  • TGF-β1 is formed by the enzymatic cleavage of the TGF-β1 propeptide that is encoded by the TGFB1 gene and comprised of the Latency Associated Peptide (LAP) and TGF-β1
  • Prior to secretion, the dimeric LAP-TGF-β1 propeptide is cleaved resulting in a biologically inactive form of dimeric TGF-β1 that is noncovalently associated with dimeric LAP (latent TGF-β 1)
  • This complex may be expressed on the surface of TGF-β1-producing cells or be further processed by proteolytic removal of LAP to release the biologically active mature form of the soluble TGF-β1 homodimer
  • Many different cell types synthesize TGF-β1 and express specific receptors for it
  • The TW4-9E7 antibody recognizes both the intracellular latent bound form of TGF-β1 along with the membrane bound form of TGF-β1.